ESTA - Establishment Labs Holdings - Stock & Dividends
Exchange: USA Stocks • Country: Costa Rica • Currency: USD • Type: Common Stock • ISIN: VGG312491084
Breast Implants, Tissue Expanders
Establishment Labs Holdings Inc., a pioneering medical technology company, specializes in designing and manufacturing innovative medical devices for aesthetic and reconstructive plastic surgery. At the forefront of their product line is the Motiva Implants brand, which features a range of silicone gel-filled breast implants that cater to diverse patient needs.
The company's product portfolio is further diversified with the Motiva Ergonomix and Motiva Ergonomix2 gravity-sensitive round soft silicone-gel-filled breast implants, designed to provide a more natural look and feel. Additionally, the Motiva Flora Tissue Expander, a breast tissue expander, is another key offering that enables surgeons to achieve optimal results in breast reconstruction procedures.
Establishment Labs Holdings Inc. has established a strong global presence, with a robust distribution network that spans across Europe, the Middle East, Latin America, and Asia. The company's products are sold to physicians, hospitals, and clinics through a combination of distributors and a direct sales force, ensuring that their innovative solutions reach a wide range of customers.
With a rich history dating back to 2004, Establishment Labs Holdings Inc. is headquartered in Alajuela, Costa Rica, and continues to drive innovation in the field of aesthetic and reconstructive plastic surgery. For more information, please visit their website at https://www.establishmentlabs.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
ESTA Stock Overview
Market Cap in USD | 1,145m |
Sector | Healthcare |
Industry | Medical Devices |
GiC SubIndustry | Health Care Supplies |
TER | 0.00% |
IPO / Inception | 2018-07-19 |
ESTA Stock Ratings
Growth 5y | 44.7 |
Fundamental | -60.8 |
Dividend | 0.00 |
Rel. Performance vs Sector | 0.71 |
Analysts | 4.57/5 |
Fair Price Momentum | 46.41 USD |
Fair Price DCF | - |
ESTA Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
ESTA Growth Ratios
Growth 12m | 21.04% |
Growth Correlation 12m | 51.5% |
Growth Correlation 3m | -25% |
CAGR 5y | 17.75% |
CAGR/Mean DD 5y | 0.60 |
Sharpe Ratio 12m | 0.22 |
Alpha vs SP500 12m | -40.15 |
Beta vs SP500 5y weekly | 1.68 |
ValueRay RSI | 55.83 |
Volatility GJR Garch 1y | 79.42% |
Price / SMA 50 | -1.17% |
Price / SMA 200 | -5.5% |
Current Volume | 190k |
Average Volume 20d | 616.2k |
External Links for ESTA Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 18, 2024, the stock is trading at USD 42.29 with a total of 189,994 shares traded.
Over the past week, the price has changed by +9.02%, over one month by -2.92%, over three months by -11.01% and over the past year by +24.35%.
According to ValueRays Forecast Model, ESTA Establishment Labs Holdings will be worth about 52.1 in October 2025. The stock is currently trading at 42.29. This means that the stock has a potential upside of +23.08%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 62.2 | 47.0 |
Analysts Target Price | 87.9 | 108 |
ValueRay Target Price | 52.1 | 23.1 |